{
  "success": true,
  "pagesUsed": [
    4,
    11,
    13,
    22
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "PROTOCOL AMENDMENT ACCEPTANCE FORM",
        "text": "PROTOCOL AMENDMENT ACCEPTANCE FORM",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionTitle": "PROTOCOL AMENDMENT ACCEPTANCE FORM",
        "sectionType": {
          "id": "b9e383fe-1b69-4557-8031-2c21b8c2d58c",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "PROTOCOL SYNOPSIS",
        "text": "PROTOCOL SYNOPSIS",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionTitle": "PROTOCOL SYNOPSIS",
        "sectionType": {
          "id": "887b7e0e-f9b5-4b01-8590-e1f825a3a145",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_3",
        "name": "BACKGROUND",
        "text": "BACKGROUND",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "BACKGROUND",
        "sectionType": {
          "id": "a881ee16-e0e8-41db-b0ab-ae85179963e4",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_3_1",
          "nci_3_2",
          "nci_3_3"
        ]
      },
      {
        "id": "nc_4",
        "name": "OBJECTIVES AND ENDPOINTS",
        "text": "OBJECTIVES AND ENDPOINTS",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "OBJECTIVES AND ENDPOINTS",
        "sectionType": {
          "id": "a114298a-39cb-4dda-8f24-5c6ce459115b",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3",
          "nci_4_4",
          "nci_4_5",
          "nci_4_6"
        ]
      },
      {
        "id": "nc_5",
        "name": "STUDY DESIGN",
        "text": "STUDY DESIGN",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "STUDY DESIGN",
        "sectionType": {
          "id": "ae021af2-a225-4191-be34-f4cb6f2927f8",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_5_1"
        ]
      },
      {
        "id": "nc_6",
        "name": "Schedule of Activities",
        "text": "Schedule of Activities",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 1",
        "sectionTitle": "Schedule of Activities",
        "sectionType": {
          "id": "ad80dd43-f69f-43f8-9ca7-d78a74d9082f",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_7",
        "name": "Unscheduled Safety Assessment Visit",
        "text": "Unscheduled Safety Assessment Visit",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 2",
        "sectionTitle": "Unscheduled Safety Assessment Visit",
        "sectionType": {
          "id": "45062557-40b2-415f-96f3-50a181e79171",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_8",
        "name": "Study Treatment Preparation",
        "text": "Study Treatment Preparation",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 3",
        "sectionTitle": "Study Treatment Preparation",
        "sectionType": {
          "id": "891bc26f-27e3-4cba-b3fa-7f23dac88f72",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_9",
        "name": "Grading Scale for Assessment of Anterior Chamber Flare or Cells and Vitreous Cell",
        "text": "Grading Scale for Assessment of Anterior Chamber Flare or Cells and Vitreous Cell",
        "order": 8,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 4",
        "sectionTitle": "Grading Scale for Assessment of Anterior Chamber Flare or Cells and Vitreous Cell",
        "sectionType": {
          "id": "6c7df861-5e02-4cac-a110-861f78048e14",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_10",
        "name": "Refraction and Best-Corrected Visual Acuity Testing",
        "text": "Refraction and Best-Corrected Visual Acuity Testing",
        "order": 9,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 5",
        "sectionTitle": "Refraction and Best-Corrected Visual Acuity Testing",
        "sectionType": {
          "id": "76fa304d-1d98-44b7-bff7-5bcd194bbdb8",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_11",
        "name": "Color Fundus Photography",
        "text": "Color Fundus Photography",
        "order": 10,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 6",
        "sectionTitle": "Color Fundus Photography",
        "sectionType": {
          "id": "b9e82bea-d7a6-436c-ad70-769b1470bebe",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_12",
        "name": "Fundus Fluorescein Angiography",
        "text": "Fundus Fluorescein Angiography",
        "order": 11,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 7",
        "sectionTitle": "Fundus Fluorescein Angiography",
        "sectionType": {
          "id": "7039584a-b512-4907-bd0c-07d7b8b4d2d5",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_13",
        "name": "Spectral-Domain Optical Coherence Tomography",
        "text": "Spectral-Domain Optical Coherence Tomography",
        "order": 12,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 8",
        "sectionTitle": "Spectral-Domain Optical Coherence Tomography",
        "sectionType": {
          "id": "4635852c-2218-40f8-bdb3-ddb2154302d9",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_14",
        "name": "Biological Sample Collection and Shipping Instructions",
        "text": "Biological Sample Collection and Shipping Instructions",
        "order": 13,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 9",
        "sectionTitle": "Biological Sample Collection and Shipping Instructions",
        "sectionType": {
          "id": "72b21031-e75a-4cb4-8a47-63b2e20f52f5",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_15",
        "name": "National Eye Institute 25-Item Visual Functioning Questionnaire",
        "text": "National Eye Institute 25-Item Visual Functioning Questionnaire",
        "order": 14,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 10",
        "sectionTitle": "National Eye Institute 25-Item Visual Functioning Questionnaire",
        "sectionType": {
          "id": "9cd66846-2e3a-4d91-9078-ed1b8217cc1a",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_3_1",
        "name": "Background on Retinal Vein Occlusion",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "Background on Retinal Vein Occlusion"
      },
      {
        "id": "nci_3_2",
        "name": "Background on Faricimab",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2",
        "sectionTitle": "Background on Faricimab"
      },
      {
        "id": "nci_3_3",
        "name": "Study Rationale and Benefit-Risk Assessment",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3",
        "sectionTitle": "Study Rationale and Benefit-Risk Assessment"
      },
      {
        "id": "nci_4_1",
        "name": "Efficacy Objectives",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "Efficacy Objectives"
      },
      {
        "id": "nci_4_2",
        "name": "Safety Objective",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "Safety Objective"
      },
      {
        "id": "nci_4_3",
        "name": "Pharmacokinetic Objectives",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3",
        "sectionTitle": "Pharmacokinetic Objectives"
      },
      {
        "id": "nci_4_4",
        "name": "Immunogenicity Objectives",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.4",
        "sectionTitle": "Immunogenicity Objectives"
      },
      {
        "id": "nci_4_5",
        "name": "Exploratory Biomarker Objective",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.5",
        "sectionTitle": "Exploratory Biomarker Objective"
      },
      {
        "id": "nci_4_6",
        "name": "Exploratory Substudy",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.6",
        "sectionTitle": "Exploratory Substudy"
      },
      {
        "id": "nci_5_1",
        "name": "Description of the Study",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "Description of the Study"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "ADA",
        "expandedText": "anti-drug antibody",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "BCVA",
        "expandedText": "best-corrected visual acuity",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "BRVO",
        "expandedText": "branch retinal vein occlusion",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "CFP",
        "expandedText": "color fundus photograph",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "CNV",
        "expandedText": "choroidal neovascularization",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "CRC",
        "expandedText": "central reading center",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "CRVO",
        "expandedText": "central retinal vein occlusion",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "CST",
        "expandedText": "central subfield thickness",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "DME",
        "expandedText": "diabetic macular edema",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "DR",
        "expandedText": "diabetic retinopathy",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "EC",
        "expandedText": "Ethics Committee",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "eCRF",
        "expandedText": "electronic Case Report Form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "EDC",
        "expandedText": "electronic data capture",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "ETDRS",
        "expandedText": "Early Treatment Diabetic Retinopathy Study",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_15",
        "abbreviatedText": "FFA",
        "expandedText": "fundus fluorescein angiography",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_16",
        "abbreviatedText": "HIPAA",
        "expandedText": "Health Insurance Portability and Accountability Act",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_17",
        "abbreviatedText": "HRVO",
        "expandedText": "hemiretinal vein occlusion",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_18",
        "abbreviatedText": "ICH",
        "expandedText": "International Council for Harmonisation",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_19",
        "abbreviatedText": "iDCC",
        "expandedText": "independent Data Coordinating Center",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_20",
        "abbreviatedText": "iDMC",
        "expandedText": "independent Data Monitoring Committee",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_21",
        "abbreviatedText": "IL",
        "expandedText": "interleukin",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_22",
        "abbreviatedText": "IMP",
        "expandedText": "investigational medicinal product",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_23",
        "abbreviatedText": "IND",
        "expandedText": "Investigational New Drug (Application)",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_24",
        "abbreviatedText": "IOP",
        "expandedText": "intraocular pressure",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_25",
        "abbreviatedText": "IRB",
        "expandedText": "Institutional Review Board",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_26",
        "abbreviatedText": "ITT",
        "expandedText": "intent-to-treat (population)",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_27",
        "abbreviatedText": "IVT",
        "expandedText": "intravitreal",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_28",
        "abbreviatedText": "IxRS",
        "expandedText": "interactive web-based response system",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_29",
        "abbreviatedText": "LPLV",
        "expandedText": "last patient, last visit",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_30",
        "abbreviatedText": "MMRM",
        "expandedText": "mixed model for repeated measures",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_31",
        "abbreviatedText": "nAMD",
        "expandedText": "neovascular age-related macular degeneration",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_32",
        "abbreviatedText": "NEI VFQ-25",
        "expandedText": "National Eye Institute 25-Item Visual Functioning Questionnaire",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_33",
        "abbreviatedText": "NIMP",
        "expandedText": "non-investigational medicinal product",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_34",
        "abbreviatedText": "NMPA",
        "expandedText": "(China) National Medical Products Administration",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_35",
        "abbreviatedText": "OCT",
        "expandedText": "optical coherence tomography",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_36",
        "abbreviatedText": "PTI",
        "expandedText": "personalized treatment interval",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_37",
        "abbreviatedText": "Q4W",
        "expandedText": "every 4 weeks",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_38",
        "abbreviatedText": "Q16W",
        "expandedText": "every 16 weeks",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 15,
      "itemCount": 10,
      "abbreviationCount": 38
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATOR-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FARICIMAB IN PATIENTS WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "2",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8",
        "nc_9",
        "nc_10",
        "nc_11",
        "nc_12",
        "nc_13",
        "nc_14",
        "nc_15"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "ADA",
          "expansion": "anti-drug antibody"
        },
        {
          "abbreviation": "BCVA",
          "expansion": "best-corrected visual acuity"
        },
        {
          "abbreviation": "BRVO",
          "expansion": "branch retinal vein occlusion"
        },
        {
          "abbreviation": "CFP",
          "expansion": "color fundus photograph"
        },
        {
          "abbreviation": "CNV",
          "expansion": "choroidal neovascularization"
        },
        {
          "abbreviation": "CRC",
          "expansion": "central reading center"
        },
        {
          "abbreviation": "CRVO",
          "expansion": "central retinal vein occlusion"
        },
        {
          "abbreviation": "CST",
          "expansion": "central subfield thickness"
        },
        {
          "abbreviation": "DME",
          "expansion": "diabetic macular edema"
        },
        {
          "abbreviation": "DR",
          "expansion": "diabetic retinopathy"
        },
        {
          "abbreviation": "EC",
          "expansion": "Ethics Committee"
        },
        {
          "abbreviation": "eCRF",
          "expansion": "electronic Case Report Form"
        },
        {
          "abbreviation": "EDC",
          "expansion": "electronic data capture"
        },
        {
          "abbreviation": "ETDRS",
          "expansion": "Early Treatment Diabetic Retinopathy Study"
        },
        {
          "abbreviation": "FFA",
          "expansion": "fundus fluorescein angiography"
        },
        {
          "abbreviation": "HIPAA",
          "expansion": "Health Insurance Portability and Accountability Act"
        },
        {
          "abbreviation": "HRVO",
          "expansion": "hemiretinal vein occlusion"
        },
        {
          "abbreviation": "ICH",
          "expansion": "International Council for Harmonisation"
        },
        {
          "abbreviation": "iDCC",
          "expansion": "independent Data Coordinating Center"
        },
        {
          "abbreviation": "iDMC",
          "expansion": "independent Data Monitoring Committee"
        },
        {
          "abbreviation": "IL",
          "expansion": "interleukin"
        },
        {
          "abbreviation": "IMP",
          "expansion": "investigational medicinal product"
        },
        {
          "abbreviation": "IND",
          "expansion": "Investigational New Drug (Application)"
        },
        {
          "abbreviation": "IOP",
          "expansion": "intraocular pressure"
        },
        {
          "abbreviation": "IRB",
          "expansion": "Institutional Review Board"
        },
        {
          "abbreviation": "ITT",
          "expansion": "intent-to-treat (population)"
        },
        {
          "abbreviation": "IVT",
          "expansion": "intravitreal"
        },
        {
          "abbreviation": "IxRS",
          "expansion": "interactive web-based response system"
        },
        {
          "abbreviation": "LPLV",
          "expansion": "last patient, last visit"
        },
        {
          "abbreviation": "MMRM",
          "expansion": "mixed model for repeated measures"
        },
        {
          "abbreviation": "nAMD",
          "expansion": "neovascular age-related macular degeneration"
        },
        {
          "abbreviation": "NEI VFQ-25",
          "expansion": "National Eye Institute 25-Item Visual Functioning Questionnaire"
        },
        {
          "abbreviation": "NIMP",
          "expansion": "non-investigational medicinal product"
        },
        {
          "abbreviation": "NMPA",
          "expansion": "(China) National Medical Products Administration"
        },
        {
          "abbreviation": "OCT",
          "expansion": "optical coherence tomography"
        },
        {
          "abbreviation": "PTI",
          "expansion": "personalized treatment interval"
        },
        {
          "abbreviation": "Q4W",
          "expansion": "every 4 weeks"
        },
        {
          "abbreviation": "Q16W",
          "expansion": "every 16 weeks"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATOR-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FARICIMAB IN PATIENTS WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION",
        "version": "2",
        "versionDate": null
      },
      "sections": [
        {
          "number": null,
          "title": "PROTOCOL AMENDMENT ACCEPTANCE FORM",
          "type": "Other"
        },
        {
          "number": null,
          "title": "PROTOCOL SYNOPSIS",
          "type": "Synopsis"
        },
        {
          "number": "1",
          "title": "BACKGROUND",
          "type": "Introduction",
          "subsections": [
            {
              "number": "1.1",
              "title": "Background on Retinal Vein Occlusion"
            },
            {
              "number": "1.2",
              "title": "Background on Faricimab"
            },
            {
              "number": "1.3",
              "title": "Study Rationale and Benefit-Risk Assessment",
              "subsections": [
                {
                  "number": "1.3.1",
                  "title": "Benefits"
                },
                {
                  "number": "1.3.2",
                  "title": "Risks"
                },
                {
                  "number": "1.3.3",
                  "title": "Conclusions"
                }
              ]
            }
          ]
        },
        {
          "number": "2",
          "title": "OBJECTIVES AND ENDPOINTS",
          "type": "Objectives",
          "subsections": [
            {
              "number": "2.1",
              "title": "Efficacy Objectives",
              "subsections": [
                {
                  "number": "2.1.1",
                  "title": "Primary Efficacy Objective"
                },
                {
                  "number": "2.1.2",
                  "title": "Secondary Efficacy Objectives"
                },
                {
                  "number": "2.1.3",
                  "title": "Exploratory Efficacy Objective"
                }
              ]
            },
            {
              "number": "2.2",
              "title": "Safety Objective"
            },
            {
              "number": "2.3",
              "title": "Pharmacokinetic Objectives"
            },
            {
              "number": "2.4",
              "title": "Immunogenicity Objectives"
            },
            {
              "number": "2.5",
              "title": "Exploratory Biomarker Objective"
            },
            {
              "number": "2.6",
              "title": "Exploratory Substudy"
            }
          ]
        },
        {
          "number": "3",
          "title": "STUDY DESIGN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "3.1",
              "title": "Description of the Study",
              "subsections": [
                {
                  "number": "3.1.1",
                  "title": "Overview of Study Design",
                  "subsections": [
                    {
                      "number": "3.1.1.1",
                      "title": "Screening"
                    },
                    {
                      "number": "3.1.1.2",
                      "title": "Re-Screening"
                    },
                    {
                      "number": "3.1.1.3",
                      "title": "Randomization and Visit Schedule"
                    }
                  ]
                },
                {
                  "number": "3.1.2",
                  "title": "Compliance with Study Visits, Handling of Missed Visits, and Timely Reporting",
                  "subsections": [
                    {
                      "number": "3.1.2.1",
                      "title": "Timely Forwarding of OCT Images to the Central Reading Center or Reporting of Missed OCT Images"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "number": "Appendix 1",
          "title": "Schedule of Activities",
          "type": "Appendix"
        },
        {
          "number": "Appendix 2",
          "title": "Unscheduled Safety Assessment Visit",
          "type": "Appendix"
        },
        {
          "number": "Appendix 3",
          "title": "Study Treatment Preparation",
          "type": "Appendix"
        },
        {
          "number": "Appendix 4",
          "title": "Grading Scale for Assessment of Anterior Chamber Flare or Cells and Vitreous Cell",
          "type": "Appendix"
        },
        {
          "number": "Appendix 5",
          "title": "Refraction and Best-Corrected Visual Acuity Testing",
          "type": "Appendix"
        },
        {
          "number": "Appendix 6",
          "title": "Color Fundus Photography",
          "type": "Appendix"
        },
        {
          "number": "Appendix 7",
          "title": "Fundus Fluorescein Angiography",
          "type": "Appendix"
        },
        {
          "number": "Appendix 8",
          "title": "Spectral-Domain Optical Coherence Tomography",
          "type": "Appendix"
        },
        {
          "number": "Appendix 9",
          "title": "Biological Sample Collection and Shipping Instructions",
          "type": "Appendix"
        },
        {
          "number": "Appendix 10",
          "title": "National Eye Institute 25-Item Visual Functioning Questionnaire",
          "type": "Appendix"
        }
      ]
    }
  }
}